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Background: Both Angio-SealTM and MynxTM are widely used vascular closure devices (VCDs) in the cardiac catheterization laboratory. However, 
their comparative safety has not been established in any large scale study.
Methods: We conducted a cohort analysis, using ICD-9 coding data from the Premier Perspective Database, of 84,675 patients who received VCD 
(10.2% Mynx, 89.8% Angio-Seal) from January 2008 to December 2009. Diagnostic and interventional procedures were analyzed separately. Primary 
endpoints consisted of procedure-related bleeding/hematoma, blood transfusion, vessel closure, arteriovenous fistula and pseudoaneurysm. The 
independent effect of closure device on the prespecified outcomes was examined using multivariate logistic regression analyses (MVA). Covariates 
in the MVA model were age, gender, hypertension, diabetes, hyperlipidemia, chronic kidney disease, cerebrovascular disease, peripheral vascular 
disease, smoking, low body weight and concomitant antiplatelet/anticoagulant therapy. Propensity score matched analysis was also used to 
compare endpoints between the two groups.
Results: Of the vascular complications, bleeding and transfusion were found to be different between the groups Table 1. 
Table 1. Results
Odds Ratio Angio-Seal vs. Mynx
(95% CI)
P Value
MVA Diagnostic
(Multivariate Analysis)
Bleeding 1.14 (0.93-1.40) 0.21
Transfusion 0.59 (0.50-0.70) <0.0001
MVA Intervention Bleeding 0.74 (0.59-0.92) <0.0075Transfusion 0.40 (0.29-0.55) <0.0001
Mynx Angio-Seal
PSM Diagnostic
(Propensity Score Matched)
Bleeding 1.7% (69/4009)
2.0%
(158/8018)
0.34
Transfusion
3.1%
(123/4009)
1.6%
(129/8018)
<0.001
PSM Intervention Bleeding 3.3% (91/2780) 2.5% (209/8340) 0.03Transfusion 1.7% (46/2780) 0.7% (58/8340) <0.001
Conclusions: Use of Angio-Seal was associated with lower bleeding in the intervention subgroup while having lower transfusion rates in both 
diagnostic and intervention subgroups. This finding may reflect learning curve associated with a relatively new VCD, Mynx.
